Taking this into account, Piper Sandler initiated its Immatics N.V [IMTX] rating to an Overweight in a research note published on October 07, 2024; the price target was $19. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early November with a ‘”an Overweight”‘ rating. Mizuho began covering IMTX with “Buy” recommendation on March 31, 2023. Bryan Garnier started covering the stock on March 24, 2023. It rated IMTX as “a Buy”.
Price Performance Review of IMTX
On Tuesday, Immatics N.V [NASDAQ:IMTX] saw its stock fall -10.00% to $4.59. Over the last five days, the stock has lost -5.75%. Immatics N.V shares have fallen nearly -35.44% since the year began. Nevertheless, the stocks have fallen -57.85% over the past one year. While a 52-week high of $13.77 was reached on 01/02/25, a 52-week low of $3.30 was recorded on 04/07/25. SMA at 50 days reached $4.50, while 200 days put it at $7.85.
Levels Of Support And Resistance For IMTX Stock
The 24-hour chart illustrates a support level at 4.37, which if violated will result in even more drops to 4.14. On the upside, there is a resistance level at 5.03. A further resistance level may holdings at 5.46. The Relative Strength Index (RSI) on the 14-day chart is 49.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.32, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.42%. Stochastics %K at 68.36% indicates the stock is a holding.
The most recent change occurred on November 20, 2020 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $13 price target.
